
Conference Coverage
about 1 month ago
Zidesamtinib Elicits Responses in ROS1-Positive NSCLCabout 1 month ago
Tagrisso With Chemotherapy Improves Survival in EGFR+ NSCLCabout 1 month ago
Dispelling Myths and Raising Awareness of Lung Cancer RiskLatest Content

Managing Emotional and Physical Side Effects of Lung Cancer Treatment

FDA Fast Tracks NG-350A for Some With Advanced Rectal Cancer

Can Exercise Improve Cancer Survival After Treatment?

Fruzaqla and Tyvyt Combo Shows Improved Outcomes in Advanced Kidney Cancer

Vonjo Improves Blood Counts in Patients With Myelofibrosis and Anemia

Shorts






Podcasts
Videos
All News

Dr. Anjana Pillai highlights Liver Cancer Awareness Month’s role in promoting liver health, dispelling myths and encouraging early detection and care.

Thoughts on life, multiple myeloma, architecture and Douglas Adams.

CURE spoke with Betsy Hamlin, who was treated with Keytruda Qlex in a clinical trial after being diagnosed with melanoma.

The FDA granted breakthrough therapy designation to sonrotoclax for adults with relapsed or refractory mantle cell lymphoma, based on phase 1/2 data.

Dr. Komal Jhaveri says Breast Cancer Awareness Month should move beyond pink ribbons to drive early detection, research and equitable care.

I was sitting in my oncologist's office, listening to her explain my treatment plan, when a strange thought crossed my mind: this feels familiar.

While Breast Cancer Awareness Month raises funds and awareness, for survivors, it can painfully remind them of all they’ve endured.

The challenges of being diagnosed with a rare cancer are real, but so is the strength that comes from thriving through it.

Dr. Evan Garfein explains how 3D printing and tissue-engineered implants could make breast reconstruction safer and less taxing on the body.

Brittney Nichols highlights the need for early detection and stresses that lung cancer is not only caused by smoking; anyone can develop the disease.

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

CURE spoke with Dr. Komal Jhaveri about the findings of the EMBER-3 clinical trial.

Pelvic health therapist Dr. Alison Ankiewicz helps women manage pain, intimacy issues and bladder or bowel problems that can follow cancer treatment.

CURE spoke with melanoma survivor Betsy Hamlin about her experience with subcutaneous Keytruda in a clinical trial.

Dr. Evan Garfein discussed OnPlant, a 3D breast model, and stressed timely reconstructive care for all patients during Breast Cancer Awareness Month.